Targeted Oncology Staff

Julio Chavez, MD, MD, discussed treatment options for LBCL after relapsing on CAR T-cell therapy.

Experts discussed challenges with treating relapsed or refractory diffuse large B-cell lymphoma.

Experts discussed treatment for patients with transplant-ineligible diffuse large B-cell lymphoma.

Early safety and efficacy data support the use of natural killer T (NKT) cells in patients with stage IV relapsed/refractory neuroblastoma.